BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31772637)

  • 1. Dexmedetomidine activates the PI3K/Akt pathway to inhibit hepatocyte apoptosis in rats with obstructive jaundice.
    Xie Y; Guo C; Liu Y; Shi L; Yu J
    Exp Ther Med; 2019 Dec; 18(6):4461-4466. PubMed ID: 31772637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin augments activation of liver regeneration through attenuating transforming growth factor-β1 induced-apoptosis in obstructive jaundice rats.
    Fang D; He Y; Luan Z
    Exp Ther Med; 2017 Nov; 14(5):4839-4845. PubMed ID: 29201188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yinchenhao decoction attenuates obstructive jaundice-induced liver injury and hepatocyte apoptosis by suppressing protein kinase RNA-like endoplasmic reticulum kinase-induced pathway.
    Wu YL; Li ZL; Zhang XB; Liu H
    World J Gastroenterol; 2019 Nov; 25(41):6205-6221. PubMed ID: 31749592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine Attenuates Lung Injury in Obstructive Jaundice Rats Through PI3K/Akt/HIF-1α Signaling Pathway.
    Shi L; Guo C; Xie Y; Liu Y; Wu F
    Arch Med Res; 2019 Jul; 50(5):233-240. PubMed ID: 31589938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstructive jaundice increases sensitivity to lipopolysaccharide via TLR4 upregulation: possible involvement in gut-derived hepatocyte growth factor-protection of hepatocytes.
    Miyaso H; Morimoto Y; Ozaki M; Haga S; Shinoura S; Choda Y; Iwagaki H; Tanaka N
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1859-66. PubMed ID: 16336445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome
    Deng X; Deng T; Ni Y; Zhan Y; Huang W; Liu J; Liao C
    Exp Ther Med; 2016 Jul; 12(1):333-342. PubMed ID: 27347059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFkappaB inhibition decreases hepatocyte proliferation but does not alter apoptosis in obstructive jaundice.
    Bird MA; Black D; Lange PA; Samson CM; Hayden M; Behrns KE
    J Surg Res; 2003 Oct; 114(2):110-7. PubMed ID: 14559434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive inflammation but decreased immunological response renders liver susceptible to infection in bile duct ligated mice.
    Morita Y; Yoshidome H; Kimura F; Shimizu H; Ohtsuka M; Takeuchi D; Mitsuhashi N; Iida A; Miyazaki M
    J Surg Res; 2008 May; 146(2):262-70. PubMed ID: 18061617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen-rich saline protects against liver injury in rats with obstructive jaundice.
    Liu Q; Shen WF; Sun HY; Fan DF; Nakao A; Cai JM; Yan G; Zhou WP; Shen RX; Yang JM; Sun XJ
    Liver Int; 2010 Aug; 30(7):958-68. PubMed ID: 20492513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway.
    Liang S; Wang Y; Liu Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):370-377. PubMed ID: 30657579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of AKT and sphingosine kinase in the antiapoptotic effects of bile duct ligation in mouse liver.
    Osawa Y; Hannun YA; Proia RL; Brenner DA
    Hepatology; 2005 Dec; 42(6):1320-8. PubMed ID: 16317686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen-rich saline protects against mitochondrial dysfunction and apoptosis in mice with obstructive jaundice.
    Liu Q; Li BS; Song YJ; Hu MG; Lu JY; Gao A; Sun XJ; Guo XM; Liu R
    Mol Med Rep; 2016 Apr; 13(4):3588-96. PubMed ID: 26936224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dexmedetomidine on sepsis-induced liver injury in rats.
    Li XK; Yang SC; Bi L; Jia Z
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):177-183. PubMed ID: 31389589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine suppresses sevoflurane anesthesia-induced neuroinflammation through activation of the PI3K/Akt/mTOR pathway.
    Wang N; Wang M
    BMC Anesthesiol; 2019 Jul; 19(1):134. PubMed ID: 31351473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms.
    Zi SF; Li JH; Liu L; Deng C; Ao X; Chen DD; Wu SZ
    Int Immunopharmacol; 2019 Nov; 76():105898. PubMed ID: 31520992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of protein kinase C and fructose in hepatic injury caused by obstructive jaundice.
    Wang J; Wang H; Xiao B; Zou S
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(4):435-8. PubMed ID: 16196296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone decreases cholestatic liver injury via inhibition of intrinsic pathway with simultaneous enhancement of mitochondrial biogenesis.
    Tiao MM; Lin TK; Chen JB; Liou CW; Wang PW; Huang CC; Chou YM; Huang YH; Chuang JH
    Steroids; 2011 Jun; 76(7):660-6. PubMed ID: 21419148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin attenuates oxidative stress, liver damage and hepatocyte apoptosis after bile-duct ligation in rats.
    Aktas C; Kanter M; Erboga M; Mete R; Oran M
    Toxicol Ind Health; 2014 Oct; 30(9):835-44. PubMed ID: 23095487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestatic liver injury increases circulating TNF-alpha and IL-6 and mortality after Escherichia coli endotoxemia.
    Lechner AJ; Velasquez A; Knudsen KR; Johanns CA; Tracy TF; Matuschak GM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1550-8. PubMed ID: 9603137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NF-kappaB inhibitors attenuate hepatic injury in bile duct ligated rats.
    Demirbilek S; Akin M; Gürünlüoğlu K; Aydin NE; Emre MH; Taş E; Aksoy RT; Ay S
    Pediatr Surg Int; 2006 Aug; 22(8):655-63. PubMed ID: 16830161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.